Cullinan Therapeutics, Inc.
CGEM
$16.33
$0.181.12%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -6.01% | -9.64% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.83% | -0.60% | |||
| Operating Income | 2.83% | 0.60% | |||
| Income Before Tax | 2.07% | -0.20% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 2.07% | -0.20% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 2.07% | -0.20% | |||
| EBIT | 2.83% | 0.60% | |||
| EBITDA | 2.83% | 0.61% | |||
| EPS Basic | 4.11% | 0.01% | |||
| Normalized Basic EPS | 4.13% | 0.00% | |||
| EPS Diluted | 4.11% | 0.01% | |||
| Normalized Diluted EPS | 4.13% | 0.00% | |||
| Average Basic Shares Outstanding | 2.13% | 0.21% | |||
| Average Diluted Shares Outstanding | 2.13% | 0.21% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||